Induced maturation of human immunodeficiency virus

Journal of Virology

Volumn 88, Issue 23, 2014, Pages 13722-13731

  Mattei, Simone ^a,c   Anders, Maria ^b   Konvalinka, Jan ^d   Kräusslich, Hans Georg ^b,c   Briggs, John A G ^a,c   Müller, Barbara ^b,c  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Molecular Medicine Partnership Unit   (Germany)

^d CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; POLYPROTEIN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; HALF LIFE TIME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMATURE VIRUS; IN VITRO STUDY; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN PROCESSING; STRUCTURE ANALYSIS; VIRAL PHENOMENA AND FUNCTIONS; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS INFECTIVITY; VIRUS MATURATION; VIRUS PARTICLE; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES; VIROLOGY; VIRUS RELEASE;

HUMAN IMMUNODEFICIENCY VIRUS;

HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; VIROLOGY; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84911371451     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02271-14     Document Type: Article

References (59)

1. Briggs JA, Krausslich HG. 2011. The molecular architecture of HIV. J. Mol. Biol. 410:491-500. http://dx.doi.org/10.1016/j.jmb.2011.04.021.
2. Ganser-Pornillos BK, Yeager M, Pornillos O. 2012. Assembly and architecture of HIV. Adv. Exp. Med. Biol. 726:441-465. http://dx.doi.org/10 .1007/978-1-4614-0980-9_20.
3. Sundquist WI, Krausslich HG. 2012. HIV-1 assembly, budding, and maturation. Cold Spring Harb. Perspect. Med. 2:a006924. http://dx.doi .org/10.1101/cshperspect.a006924.
4. Anderson J, Schiffer C, Lee SK, Swanstrom R. 2009. Viral protease inhibitors. Handb. Exp. Pharmacol. 2009(189):85-110. http://dx.doi.org /10.1007/978-3-540-79086-0_4.
5. Pokorna J, Machala L, Rezacova P, Konvalinka J. 2009. Current and novel inhibitors of HIV protease. Viruses 1:1209-1239. http://dx.doi.org /10.3390/v1031209.
6. Wensing AM, van Maarseveen NM, Nijhuis M. 2010. Fifteen years of HIV protease inhibitors: raising the barrier to resistance. Antiviral Res. 85:59-74. http://dx.doi.org/10.1016/j.antiviral.2009.10.003.
7. Benjamin J, Ganser-Pornillos BK, Tivol WF, Sundquist WI, Jensen GJ. 2005. Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J. Mol. Biol. 346:577-588. http://dx.doi.org/10 .1016/j.jmb.2004.11.064.
8. Briggs JA, Riches JD, Glass B, Bartonova V, Zanetti G, Krausslich HG. 2009. Structure and assembly of immature HIV. Proc. Natl. Acad. Sci. U. S. A. 106:11090-11095. http://dx.doi.org/10.1073/pnas.0903535106.
9. Briggs JA, Grunewald K, Glass B, Forster F, Krausslich HG, Fuller SD. 2006. The mechanism of HIV-1 core assembly: insights from threedimensional reconstructions of authentic virions. Structure 14:15-20. http://dx.doi.org/10.1016/j.str.2005.09.010.
10. Briggs JA, Wilk T, Welker R, Krausslich HG, Fuller SD. 2003. Structural organization of authentic, mature HIV-1 virions and cores. EMBO J. 22: 1707-1715. http://dx.doi.org/10.1093/emboj/cdg143.
11. Wright ER, Schooler JB, Ding HJ, Kieffer C, Fillmore C, Sundquist WI, Jensen GJ. 2007. Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J. 26:2218- 2226. http://dx.doi.org/10.1038/sj.emboj.7601664.
12. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. 1999. Assembly and analysis of conical models for the HIV-1 core. Science 283:80-83. http://dx.doi.org/10.1126/science.283.5398.80.
13. Li S, Hill CP, Sundquist WI, Finch JT. 2000. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407:409-413. http: //dx.doi.org/10.1038/35030177.
14. Bharat TA, Davey NE, Ulbrich P, Riches JD, de Marco A, Rumlova M, Sachse C, Ruml T, Briggs JA. 2012. Structure of the immature retroviral capsid at 8 A resolution by cryo-electron microscopy. Nature 487:385- 389. http://dx.doi.org/10.1038/nature11169.
15. Lanman J, Lam TT, Emmett MR, Marshall AG, Sakalian M, Prevelige PE, Jr. 2004. Key interactions in HIV-1 maturation identified by hydrogen- deuterium exchange. Nat. Struct. Mol. Biol. 11:676-677. http://dx .doi.org/10.1038/nsmb790.
16. Krausslich HG. 1991. Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc. Natl. Acad. Sci. U. S. A. 88:3213-3217. http://dx.doi.org /10.1073/pnas.88.8.3213.
17. Erickson-Viitanen S, Manfredi J, Viitanen P, Tribe DE, Tritch R, Hutchison CA, III, Loeb DD, Swanstrom R. 1989. Cleavage of HIV-1 Gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res. Human Retroviruses 5:577-591. http://dx.doi.org/10 .1089/aid.1989.5.577.
18. Pettit SC, Lindquist JN, Kaplan AH, Swanstrom R. 2005. Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates. Retrovirology 2:66. http://dx.doi.org/10.1186/1742-4690-2-66.
19. Pettit SC, Moody MD, Wehbie RS, Kaplan AH, Nantermet PV, Klein CA, Swanstrom R. 1994. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68:8017-8027.
20. Coren LV, Thomas JA, Chertova E, Sowder RC, II, Gagliardi TD, Gorelick RJ, Ott DE. 2007. Mutational analysis of the C-terminal gag cleavage sites in human immunodeficiency virus type 1. J. Virol. 81: 10047-10054. http://dx.doi.org/10.1128/JVI.02496-06.
21. de Marco A, Heuser AM, Glass B, Krausslich HG, Muller B, Briggs JA. 2012. Role of the SP2 domain and its proteolytic cleavage in HIV-1 structural maturation and infectivity. J. Virol. 86:13708-13716. http://dx.doi .org/10.1128/JVI.01704-12.
22. Wiegers K, Rutter G, Kottler H, Tessmer U, Hohenberg H, Krausslich HG. 1998. Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J. Virol. 72:2846-2854.
23. Lee SK, Potempa M, Swanstrom R. 2012. The choreography of HIV-1 proteolytic processing and virion assembly. J. Biol. Chem. 287:40867- 40874. http://dx.doi.org/10.1074/jbc.R112.399444.
24. Chojnacki J, Muller B. 2013. Investigation of HIV-1 assembly and release using modern fluorescence imaging techniques. Traffic 14:15-24. http: //dx.doi.org/10.1111/tra.12006.
25. Lata R, Conway JF, Cheng N, Duda RL, Hendrix RW, Wikoff WR, Johnson JE, Tsuruta H, Steven AC. 2000. Maturation dynamics of a viral capsid: visualization of transitional intermediate states. Cell 100:253-263. http://dx.doi.org/10.1016/S0092-8674(00)81563-9.
26. Steven AC, Heymann JB, Cheng N, Trus BL, Conway JF. 2005. Virus maturation: dynamics and mechanism of a stabilizing structural transition that leads to infectivity. Curr. Opin. Struct. Biol. 15:227-236. http: //dx.doi.org/10.1016/j.sbi.2005.03.008.
27. Manchester M, Loeb DD, Everitt L, Moody M, Hutchison CA, III, Swanstrom R. 1991. Analysis of temperature-sensitive mutants of the HIV-1 protease. Adv. Exp. Med. Biol. 306:493-497. http://dx.doi.org/10 .1007/978-1-4684-6012-4_63.
28. Konvalinka J. 1994. Structural and molecular biology of protease function and inhibition. Keystone Symposium. Santa Fe, New Mexico, March 5-12, 1994. Abstracts. J. Cell. Biochem. Suppl. 18D:117-177.
29. Sluis-Cremer N, Arion D, Abram ME, Parniak MA. 2004. Proteolytic processing of an HIV-1 pol polyprotein precursor: insights into the mechanism of reverse transcriptase p66/p51 heterodimer formation. Int. J. Biochem. Cell Biol. 36:1836-1847. http://dx.doi.org/10.1016/j.biocel .2004.02.020.
30. Adachi A, Koenig S, Gendelman HE, Daugherty D, Gattoni-Celli S, Fauci AS, Martin MA. 1987. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus. J. Virol. 61:209- 213.
31. Lampe M, Briggs JA, Endress T, Glass B, Riegelsberger S, Krausslich HG, Lamb DC, Brauchle C, Muller B. 2007. Double-labeled HIV-1 particles for study of virus-cell interaction. Virology 360:92-104. http://dx .doi.org/10.1016/j.virol.2006.10.005.
32. Dettenhofer M, Yu XF. 1999. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins. J. Virol. 73:4696- 4704.
33. Pizzato M, Erlwein O, Bonsall D, Kaye S, Muir D, McClure MO. 2009. A one-step SYBR green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. J. Virol. Methods 156:1-7. http://dx.doi.org/10.1016/j.jviromet.2008.10.012.
34. Mastronarde DN. 2005. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152:36- 51. http://dx.doi.org/10.1016/j.jsb.2005.07.007.
35. Kremer JR, Mastronarde DN, McIntosh JR. 1996. Computer visualization of three-dimensional image data using IMOD. J. Struct. Biol. 116:71- 76. http://dx.doi.org/10.1006/jsbi.1996.0013.
36. Dierynck I, De Wit M, Gustin E, Keuleers I, Vandersmissen J, Hallenberger S, Hertogs K. 2007. Binding kinetics of darunavir to human immunodeficiency virus type 1 protease explain the potent antiviral activity and high genetic barrier. J. Virol. 81:13845-13851. http://dx.doi.org/10 .1128/JVI.01184-07.
37. Markgren PO, Schaal W, Hamalainen M, Karlen A, Hallberg A, Samuelsson B, Danielson UH. 2002. Relationships between structure and interaction kinetics for HIV-1 protease inhibitors. J. Med. Chem. 45:5430- 5439. http://dx.doi.org/10.1021/jm0208370.
38. Shuman CF, Hamalainen MD, Danielson UH. 2004. Kinetic and thermodynamic characterization of HIV-1 protease inhibitors. J. Mol. Recognit. 17:106-119. http://dx.doi.org/10.1002/jmr.655.
39. Darke PL, Leu CT, Davis LJ, Heimbach JC, Diehl RE, Hill WS, Dixon RA, Sigal IS. 1989. Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease. J. Biol. Chem. 264:2307-2312.
40. Hyland LJ, Tomaszek TA, Jr, Meek TD. 1991. Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. Biochemistry 30: 8454-8463.
41. Polgar L, Szeltner Z, Boros I. 1994. Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease. Biochemistry 33:9351-9357. http://dx.doi.org/10.1021/bi00197a040.
42. Lee SK, Potempa M, Kolli M, Ozen A, Schiffer CA, Swanstrom R. 2012. Context surrounding processing sites is crucial in determining cleavage rate of a subset of processing sites in HIV-1 Gag and Gag-Pro-Pol polyprotein precursors by viral protease. J. Biol. Chem. 287:13279-13290. http://dx.doi.org/10.1074/jbc.M112.339374.
43. Konvalinka J, Heuser AM, Hruskova-Heidingsfeldova O, Vogt VM, Sedlacek J, Strop P, Krausslich HG. 1995. Proteolytic processing of particle-associated retroviral polyproteins by homologous and heterologous viral proteinases. Eur. J. Biochem. 228:191-198. http://dx.doi.org/10 .1111/j.1432-1033.1995.tb20249.x.
44. Muller B, Anders M, Akiyama H, Welsch S, Glass B, Nikovics K, Clavel F, Tervo HM, Keppler OT, Krausslich HG. 2009. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J. Biol. Chem. 284:29692-29703. http://dx.doi.org/10.1074/jbc.M109.027144.
45. Jolly C, Welsch S, Michor S, Sattentau QJ. 2011. The regulated secretory pathway in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the virological synapse. PLoS Pathog. 7:e1002226. http://dx.doi.org/10.1371/journal.ppat.1002226.
46. Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ. 2010. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J. Virol. 84:3516- 3527. http://dx.doi.org/10.1128/JVI.02651-09.
47. Konnyu B, Sadiq SK, Turanyi T, Hirmondo R, Muller B, Krausslich HG, Coveney PV, Muller V. 2013. Gag-Pol processing during HIV-1 virion maturation: a systems biology approach. PLoS Comput. Biol. 9:e1003103. http://dx.doi.org/10.1371/journal.pcbi.1003103.
48. Dale BM, McNerney GP, Thompson DL, Hubner W, de Los Reyes K, Chuang FY, Huser T, Chen BK. 2011. Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion. Cell Host Microbe 10:551-562. http://dx.doi.org /10.1016/j.chom.2011.10.015.
49. Nijhuis M, van Maarseveen NM, Lastere S, Schipper P, Coakley E, Glass B, Rovenska M, de Jong D, Chappey C, Goedegebuure IW, Heilek- Snyder G, Dulude D, Cammack N, Brakier-Gingras L, Konvalinka J, Parkin N, Krausslich HG, Brun-Vezinet F, Boucher CA. 2007. A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. PLoS Med. 4:e36. http://dx.doi.org/10.1371/journal.pmed.0040036.
50. Lee SK, Harris J, Swanstrom R. 2009. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle. J. Virol. 83:8536-8543. http://dx.doi .org/10.1128/JVI.00317-09.
51. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736.
52. Engelman A. 1999. In vivo analysis of retroviral integrase structure and function. Adv. Virus Res. 52:411-426. http://dx.doi.org/10.1016/S0065 -3527(08)60309-7.
53. Jurado KA, Wang H, Slaughter A, Feng L, Kessl JJ, Koh Y, Wang W, Ballandras-Colas A, Patel PA, Fuchs JR, Kvaratskhelia M, Engelman A. 2013. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation. Proc. Natl. Acad. Sci. U. S. A. 110:8690-8695. http://dx.doi.org/10.1073/pnas.1300703110.
54. Balakrishnan M, Yant SR, Tsai L, O'Sullivan C, Bam RA, Tsai A, Niedziela-Majka A, Stray KM, Sakowicz R, Cihlar T. 2013. Non-catalytic site HIV-1 integrase inhibitors disrupt core maturation and induce a reverse transcription block in target cells. PLoS One 8:e74163. http://dx.doi .org/10.1371/journal.pone.0074163.
55. Desimmie BA, Schrijvers R, Demeulemeester J, Borrenberghs D, Weydert C, Thys W, Vets S, Van Remoortel B, Hofkens J, De Rijck J, Hendrix J, Bannert N, Gijsbers R, Christ F, Debyser Z. 2013. LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions. Retrovirology 10:57. http://dx.doi.org/10.1186/1742 -4690-10-57.
56. Jurado KA, Engelman A. 2013. Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors. Exp. Rev. Mol. Med. 15:e14. http: //dx.doi.org/10.1017/erm.2013.15.
57. Abram ME, Parniak MA. 2005. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain. J. Virol. 79: 11952-11961. http://dx.doi.org/10.1128/JVI.79.18.11952-11961.2005.
58. Dunn LL, McWilliams MJ, Das K, Arnold E, Hughes SH. 2009. Mutations in the thumb allow human immunodeficiency virus type 1 reverse transcriptase to be cleaved by protease in virions. J. Virol. 83:12336- 12344. http://dx.doi.org/10.1128/JVI.00676-09.
59. Restle T, Muller B, Goody RS. 1990. Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention. J. Biol. Chem. 265:8986-8988.